ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679516; 2) Community: the network communities that were significantly associated with the response to NSC 679516; 3) Molecule: the relationships between components within communities and NSC 679516; 4) MDR: the compounds that were significantly associated with the NSC 679516.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0138010872611484 0.19609853
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0138010872611484 0.25009367
NSC 732178 Null 0.0138010872611484 0.23585737
NSC 737231 Null 0.0138010872611484 0.41765099
NSC 744063 Null 0.0138010872611484 0.3910677
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0138010872611484 0.049651766
NSC 114512 Null 0.0138010872611486 0.31350955
NSC 138425 Kinamycin C 0.0138010872611486 0.21172081
NSC 139105 Soluble Baker's Antifol 0.0138010872611486 0.16112537
NSC 299117 24-Norchola-20,22-diene-4-carboxaldehyde, 3,12-bis(acetyloxy)-14,15:21,23-diepoxy-1,7,19-trihydroxy-4,8-dimethyl-11-oxo-, cyclic 4,19-(acetyl acetal), [1.alpha.,3.alpha.,4.beta.(S),5.alpha.,7.alpha., 0.0138010872611486 0.51749931
Total:120  Current:54    [First] [Prev] [Next] [Last]